PEG-MGF

Price range: £12.00 through £32.00

CAS No: On request
Strengths Available: 2mg
Format: Sealed containment / vial presentations available
Volume: 3mL

What This Product Is About
PEG-MGF is frequently referenced in research exploring growth hormone (GH) and insulin-like growth factor (IGF) signalling pathways. It has attracted scientific interest as a research tool for studying how the body’s GH-axis is regulated under controlled laboratory conditions.

SKU: N/A Category:

Description

What is PEG-MGF?

PEG-MGF is a research-grade peptide studied in the context of growth hormone secretagogue and GH-axis signalling research. Investigators have explored how PEG-MGF interacts with receptors and pathways involved in the regulation of growth hormone and downstream IGF activity.

Why Researchers Became Interested in PEG-MGF

Researchers became interested in PEG-MGF because of its relevance to GH-axis regulation and the broader study of metabolic and recovery pathways.

It provides a defined research tool for examining growth-factor signalling in experimental models.

Key Research Focus Areas

  • Growth hormone secretagogue signalling models
  • GH / IGF-1 axis regulation studies
  • Metabolic and body-composition research models
  • Receptor-binding and pathway studies
  • Recovery and tissue-maintenance research
  • Endocrine signalling investigations

What the Research Has Shown

In preclinical research, PEG-MGF has been studied for its influence on growth hormone signalling pathways and related downstream activity. Mechanistic studies have explored its interaction with receptors involved in the regulation of the GH-axis.

Fast Secure Shipping
Independently Verified
Trusted by 1000s of customers
Manufactured in the U.K.

Scientific Background and Research Context

PEG-MGF is a research peptide based on mechano growth factor, a peptide sequence associated with an alternatively spliced form of the insulin-like growth factor 1 gene. MGF has been studied for its expression in tissues exposed to mechanical stress, exercise, or injury.

The term “PEG” refers to pegylation, a modification in which polyethylene glycol is attached to a peptide. In research settings, this modification is used to investigate whether greater molecular stability and a longer duration of experimental activity can be achieved.

PEG-MGF is frequently referenced in research exploring growth hormone and insulin-like growth factor signalling pathways. It has attracted scientific interest as a tool for studying how the GH–IGF axis and tissue-adaptation processes are regulated under controlled laboratory conditions.

Exploring the Science Behind

MGF is associated with local responses to mechanical loading and tissue damage. Experimental studies suggest that MGF-related peptide sequences may influence muscle progenitor cells, including their activation, proliferation, and differentiation.

PEG-MGF is studied to examine how pegylation may alter peptide stability, distribution, and duration of activity compared with non-pegylated MGF. Researchers are also interested in how MGF-related signalling interacts with cellular repair mechanisms and the broader IGF-1 pathway.

Studies involving human muscle progenitor cells have reported that the MGF E-peptide can influence cellular activity and fusion potential. However, these findings relate mainly to laboratory models and should not be interpreted as evidence of established clinical effects.

Research Context in Endocrine and Metabolic Science

The growth hormone–IGF axis plays an important role in growth, protein turnover, tissue maintenance, and metabolic regulation. PEG-MGF is therefore studied in research examining how local IGF-related signals respond to mechanical stress and communicate with wider endocrine pathways.

Research interest includes skeletal-muscle adaptation, satellite-cell biology, tissue repair, and the regulation of growth-related cellular responses. MGF expression has also been investigated in cartilage, cardiac muscle, and other tissues exposed to mechanical or biological stress.

Ongoing Scientific Interest

PEG-MGF continues to attract attention as a laboratory tool for investigating IGF-related peptide biology, tissue adaptation, and cellular repair. Researchers remain interested in understanding how pegylation affects its stability and biological behaviour, as well as how MGF-related signalling differs from full-length IGF-1 activity.

Current evidence is largely based on cellular, animal, and other preclinical research models. Further investigation is required to clarify its selectivity, pharmacological profile, and relevance to human physiology.

PEG-MGF is supplied strictly for laboratory and research purposes and is not intended for human consumption or therapeutic use.

Ingredient Profile
Single research compound: PEG-MGF
CAS: On request
Purity >99%
Supplied as lyophilised powder (no excipients, fillers or additives).

Active Ingredients
PEG-MGF — 5mg/10mg

Ingredient Breakdown
PEG-MGF: 5mg/10mg of active peptide per vial (lyophilised).

Why is PEG-MGF studied in growth-hormone research?
Because studies have explored its relevance to growth hormone and IGF-axis signalling pathways.

Is PEG-MGF approved for medical use?
No. It is supplied strictly for research and laboratory use only, and is not intended for human or veterinary use.

Why does purity matter so much for this product?
High purity helps ensure that observed research effects are due to the material itself rather than impurities.

What does ‘research grade’ mean?
It means the product is supplied with documentation and traceability for laboratory investigation.

Is international supply available?
Yes. International fulfilment and temperature-controlled shipping can be supported where appropriate.

 

Research & laboratory use only. Not for human or veterinary use. Not a medicinal product, supplement, food or medical device. No therapeutic, diagnostic, cosmetic, wellness or lifestyle claims are made or implied. Analytical reference/click information is a laboratory measurement aid only and must not be applied to living systems.

Typically supplied at >99% purity, supported by batch-specific analytical data. UK-based preparation, analysis and release under scientist-led, GMP-aligned processes with full batch-level traceability. Certificate of Analysis (CoA) available on request; independent analytical verification where appropriate.

Store the lyophilised powder refrigerated at 2–8°C, protected from light and moisture; suitable for longer-term storage frozen at -20°C. Handle under appropriate laboratory conditions. For in vitro research use only.

For in vitro laboratory research only. Reconstitution, handling and experimental design at the discretion of the qualified researcher. The 300-click sealed-containment system is an analytical measurement reference only and does not represent dosing or administration guidance. Not for use in living systems.

Partner with FreshstartPharma– Where Accuracy Meets Innovation

Freshstartpharma is committed to delivering high-quality research-grade products designed for advanced scientific applications. We offer wholesale partnerships to selected businesses that share our values of integrity, quality, and innovation. Whether you’re an established distributor or an emerging research supply company, we invite you to join our network and benefit from exclusive access to our state-of-the-art product range.